Latest Market Volatility News

8I Holdings Limited reported a net loss of S$1.09 million for FY2025, impacted by a sharp decline in investment gains due to global market volatility and new U.S. tariffs. The Group remains focused on a conservative, value-driven investment strategy despite challenging conditions.

Hancock & Gore Limited reported a statutory net loss of $3.18 million for the half-year ended 31 March 2025, impacted by unrealised investment losses despite steady dividend income from its school uniform subsidiary. The company declared a fully franked interim dividend of 1 cent per share.

Regal Partners Limited reported a stellar 2024 with a 141% jump in average funds under management to $14.4 billion and a near tripling of net profit after tax. Strategic acquisitions and offshore expansion underpin its growth trajectory.

Podium Minerals Limited has launched a fully underwritten $2.6 million entitlement offer to fund advanced metallurgical testing at its flagship Parks Reef Project, aiming to enhance platinum group metals recovery and concentrate grades.

Toro Energy has released an updated scoping study for its Lake Maitland Uranium Project, revealing robust economics with a pre-tax NPV of A$907.9 million and a swift payback period of just 1.5 years. The study outlines a 16.3-year mine life producing uranium and vanadium with modest capital expenditure and competitive operating costs.

Web Travel Group Limited reported a robust 22% increase in Total Transaction Value for FY25, despite a 14% dip in EBITDA due to margin pressures and higher costs. The company is strategically investing in supply and technology to target $10 billion TTV by FY30.

Infratil Limited reported a robust FY2025 with operational EBITDAF nearing NZ$1 billion, driven by strong performances across its core infrastructure sectors and a strategic capital raise to fuel CDC Data Centres’ expansion.

Neuren Pharmaceuticals posted record 2024 financials driven by DAYBUE royalties and advanced NNZ-2591 into Phase 3 trials, while launching a $50 million share buy-back amid volatile market sentiment.

ALS Limited reported a 16% revenue increase to nearly $3 billion in FY2025, driven by acquisitions and organic growth, while underlying net profit after tax dipped slightly. The company announced a $350 million equity raise to fund expansion and sustainability initiatives.

Elders Limited has reported a robust 67% increase in underlying EBIT for the half-year ending March 2025, driven by livestock market recovery and real estate growth, alongside five new acquisitions and ongoing transformation initiatives.

Macarthur Minerals Limited has launched a pro-rata entitlement offer to raise nearly $2 million, issuing new shares with free attaching options, fully underwritten by Gold Valley Yilgarn Pty Ltd. The capital raise aims to advance exploration and development at its Giles Lake Iron Project and support corporate operations.

Mayne Pharma has clarified why it did not disclose an FDA Untitled Letter to the market despite sharing it with its scheme bidder, reaffirming compliance with ASX rules amid recent share price volatility.